CSIMarket
 
Portage Biotech Inc   (NASDAQ: PRTG)
 
Price: $6.8100 $-0.15 -2.155%
Day's High: $9.43 Week Perf: -7.47 %
Day's Low: $ 6.80 30 Day Perf: 16.01 %
Volume (M): 388,200 52 Wk High: $ 0.00
Volume (M$): $ 2,644 52 Wk Avg: $0.00
Open: $7.60 52 Wk Low: $0.00



 Market Capitalization (Millions $) 8
 Shares Outstanding (Millions) 1
 Employees 11
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -20
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Business Description


Portage Biotech Inc. is a biopharmaceutical company that specializes in the development of innovative therapeutics for various medical conditions. They focus on identifying promising early-stage drug candidates and advancing them through the clinical development process. Portage Biotech aims to address unmet medical needs and improve patient outcomes by leveraging their expertise in drug discovery, drug development, and strategic partnerships. The company utilizes a portfolio approach to drug development, nurturing a pipeline of potential treatments across multiple therapeutic areas. Overall, Portage Biotech Inc. is dedicated to bringing forth innovative solutions to improve the lives of patients worldwide.


   Company Address: Clarence Thomas Building Tortola 0 DE
   Company Phone Number: 219 - 5556   Stock Exchange / Ticker: NASDAQ PRTG


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ADCT   -1.61%    
REGN   -1.96%    
RYTM   -3.51%    
SUPN   -3.82%    
VRTX   -4.84%    
YMAB        0.35% 
• View Complete Report
   



Shares

Portage Biotech Secures Critical Extension to Meet Stock Exchange Listing Requirements Amidst Compliance Challenges

Published Wed, Feb 12 2025 9:15 PM UTC

Portage Biotech Receives Extension to Achieve Stock Exchange ComplianceIn a significant development for Portage Biotech Inc. (NASDAQ: PTGE), the company announced that it has been granted an extension of time to meet the continued listing requirements set forth by the stock exchange. As of the writing of this article, the company s share price stands at $4.80. Understanding ...

Management Announcement

Portage Biotech Inc. Faces Declining Performance and Financial Losses, Expands Evaluation of Strategic Alternatives to Rebound in Healthcare Sector

Published Fri, Apr 12 2024 12:01 PM UTC

Portage Biotech Expands Strategic Alternatives Evaluation Amid Declining Performance and Financial Losses
Portage Biotech Inc., a leading biotechnology company, has announced its plans to expand the evaluation of strategic alternatives in a bid to improve its performance and financial standing. The company has recorded a decline in its share value by -4.65% in April 2024...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 1.52
Working Capital Ratio 2.02
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -6.97 $
Revenues (TTM) -
Cash Flow (TTM) -
Cash 1.41 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -1,833,909
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.